Idiopathic pulmonary fibrosis: Disease mechanisms and drug development
Paolo Spagnolo, Jonathan A. Kropski, Mark G. Jones, Joyce Lee, Giulio Rossi, Τheodoros Karampitsakos, Toby M. Maher, Argyrios Tzouvelekis, Christopher J. Ryerson
Topics & Concepts
NintedanibPirfenidoneIdiopathic pulmonary fibrosisMedicinePathogenesisDiseasePulmonary fibrosisFibrosisPopulationImmunologyBioinformaticsPathologyLungInternal medicineBiologyEnvironmental healthInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisSarcoidosis and Beryllium Toxicity ResearchEosinophilic Disorders and Syndromes